Modernization of Phase 3 TB Clinical Trial Endpoints |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development |
|
|
Global Fund SR2020 |
Starley Shade, PhD, MPH |
Infectious Disease, Tuberculosis, Malaria |
|
|
Adherence Monitoring impact in Global Health - Planning Grant |
Rada Savic, PhD |
Tuberculosis, Treatment Adherence |
|
|
Lesion Drug Penetration and Translational Modeling |
Rada Savic, PhD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Technical Assistance to CDC-Ukraine, Network ACCESS-Pro and the Ukrainian Public Health Center |
George Rutherford, MD |
HIV/AIDS, Infectious Disease, Transfusion Medicine, Tuberculosis, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial |
Christina Yoon, MD, MPH |
Tuberculosis |
|
|
Tackling Tuberculous Meningitis on the Ground: Bringing Advanced Diagnostics to Uganda |
Prashanth Ramachandrani, MBBS |
Tuberculosis, Drug and Diagnostics Development, Neurology and Mental Health, Training International Scholars and Clinicians |
|
|
REAC AWARD-Using mobile technologies and community health workers to find and support TB contacts in Beira, Mozambique |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Epidemiology and Surveillance |
|
|
Exhaled Breath Biomarkers for the Diagnosis of TB in Children |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development, Pediatrics |
|
|
Redefining Tuberculous Meningitis Diagnostics with Metagenomic Next Generation Sequencing |
Prashanth Ramachandran, MBBS |
Tuberculosis, Drug and Diagnostics Development |
|
|
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV |
Judith Hahn, PhD, MD |
HIV/AIDS, Tuberculosis, Substance Abuse, Residencies, Fellowships, and Postdoctoral Training |
|
|
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics |
Michael Wilson, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse |
James Kahn, MD, MPH |
HIV/AIDS, Tuberculosis, Health Economics and Effectiveness |
|
|
Conduct a systematic review of interventions to improve adherence and retention during TB and HIV co-treatment among people living with HIV |
Payam Nahid, MD, MPH |
HIV/AIDS, Tuberculosis, Systematic Reviews and Guideline Development, Treatment Adherence |
|
|
Evaluating the Impact of Cash Transfers on Tuberculosis (TB) Care: ExaCT TB Study |
Priya Shete, MD |
Tuberculosis, Health Economics and Effectiveness, Implementation and Behavioral Science |
|
|
Identifying Optimal Treatment Strategies for Tuberculosis Treatment |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
Human-centered Design and Communities of Practice to Improve Delivery of Home-based Tuberculosis Contact Investigation in Uganda |
Adithya Cattamanchi, MD |
HIV/AIDS, Tuberculosis, Engagement in Care |
|
|
PanACEA |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Epidemiology and Surveillance |
|
|
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Malaria |
|
|
Improving urine-based tuberculosis diagnosis in people living with HIV |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Engagement and retention in tuberculosis care services among people living with HIV in Lusaka, Zambia: does gender matter? |
Andrew Kerkhoff, MD, PhD |
HIV/AIDS, Tuberculosis, Stigma and Discrimination, Engagement in Care, Treatment Adherence |
|
|
Improving the efficiency of clinic-based active tuberculosis case finding: point-of-care C-reactive protein-based TB triage testing in Vietnam |
Christina Yoon, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Recent Infection Surveillance Consortium |
George Rutherford, MD |
HIV/AIDS, Tuberculosis |
|
|
Impact of Pregnancy on Tuberculosis |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Newborn and Infant Health |
|
|
Expand New Drug Markets for TB (endTB) |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Epidemiology and Surveillance |
|
|
Evaluation of the performance of rapid, non-sputum based, biomarker-based test for tuberculosis (TB) diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care and Treatment Services throughout the Health System in South Africa |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Engagement in Care, Treatment Adherence |
|
|
Clinical trials to improve the treatment of drug-sensitive and MDR-TB |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Immunology, Pharmacology and Drug Treatment |
|
|
The Yield of Tuberculosis Contact Investigation in Low-Resource, High-Burden Settings: A Systematic Review and Meta-Analysis |
Mariana Velleca, MS |
Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance |
|
|
Controlling Tuberculosis: A Cost-Effectiveness Analysis of the Drone Observed Therapy System as an Alternative Diagnostic and Treatment Method in Nepal |
Brittney Butler, MS |
Tuberculosis, Health Economics and Effectiveness |
|
|
Assessing the Acceptability and Feasibility of Using a Video-Based Education Curriculum for Tuberculosis Prevention and Control in Pyuthan District, Nepal |
Shrishti Bhattarai, MS |
Tuberculosis, Patient and Peer Education |
|
|
Combining 3HP with active case finding to maximize the impact of mass TB screening campaign in the Marshall Islands |
Christina Yoon, MD, MPH |
Tuberculosis, Diabetes, Epidemiology and Surveillance, Engagement in Care |
|
|
1180: From DOT to DAT: An evaluation of 99DOTS to improve tuberculosis treatment adherence in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Treatment Adherence |
|
|
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Health Economics and Effectiveness |
|
|
Antigen export in M. tuberculosis evasion of CD4 T cells |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Cellular and Bacterial Dynamics in Tuberculosis |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Building Evidence for Advancing New Treatment For XDR/XDR-TB (BEAT TUBERCULOSIS) Study |
Patrick Phillips, PhD, MS, MA |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment |
|
|
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis |
Felicia Chow, MD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Exhaled Breath Biomarkers for the Diagnosis of TB in Children |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Role of Antigen-Specific T Cell Responses in the Control of TB |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Overcoming socioeconomic barriers to TB care: the case for social protection |
Priya Shete, MD |
Tuberculosis, Engagement in Care, Treatment Adherence |
|
|
TB Free California |
Shereen Katrak, MD MPH |
Tuberculosis, Stigma and Discrimination, Epidemiology and Surveillance |
|
|
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy |
Michael J. Reid, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening |
|
|
Continuing Education for Health Professionals for tuberculosis patient care |
Lisa Chen, MD |
Tuberculosis, Residencies, Fellowships, and Postdoctoral Training |
|
|
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2) |
Judith Hahn, PhD, MD |
HIV/AIDS, Tuberculosis, Substance Abuse, Treatment Adherence |
|
|
Drug-Resistant Tuberculosis on the Texas-Mexico Border: Improving the Quality of bi-national TB Projects |
Camila Hurtado, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Health Education Videos for Tuberculosis Management in Remote Madagascar |
Hailey Reeves, MS |
Tuberculosis, Patient and Peer Education |
|
|
Sputum Transcriptomic Expression Profiling in Study 31: Express 31 |
Payam Nahid, MD, MPH |
HIV/AIDS, Tuberculosis |
|
|
Point-of-care C-reactive protein-based tuberculosis screening among people living with HIV: planning a comparative effectiveness trial |
Christina Yoon, MD, MPH |
HIV/AIDS, Tuberculosis |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
From Poverty to Cure: Overcoming Socioeconomic Barriers to Tuberculosis Care |
Priya Shete, MD |
Tuberculosis, Implementation and Behavioral Science |
|
|
First Lancet Commission Meeting 11-13 July 2017, San Francisco, California |
Eric Goosby, MD |
Tuberculosis, Policy and Standards of Care |
|
|
Protein secretion in bacterial pathogens |
Oren Rosenberg, MD, PhD |
Tuberculosis |
|
|
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) |
George Rutherford, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) |
George Rutherford, MD |
HIV/AIDS, Tuberculosis |
|
|
Global Fund Prospective Country Evaluations |
George Rutherford, MD |
Infectious Disease, Tuberculosis, Malaria, Women's Health, Pediatrics |
|
|
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
DOT (Directly observed therapy) Diary |
Eric Vittinghoff, PhD |
HIV/AIDS, Tuberculosis |
|
|
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan |
Timothy Lane, PhD, MPH |
HIV/AIDS, Tuberculosis, Access or Barriers to Care, Stigma and Discrimination |
|
|
Tuberculosis Epidemiologic Studies |
George Rutherford, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
3HP for LTBI in Immigrants Pilot Study |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal |
Judith Hahn, PhD, MD |
HIV/AIDS, Tuberculosis, Substance Abuse |
|
|
Operations Research Training Curriculum for Tuberculosis Control |
Lisa Chen, MD |
Tuberculosis |
|
|
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes |
|
|
Evaluation of Point-of-Care C-reactive Protein Assay as a Serial Screening Tool for Active Tuberculosis among People Living with HIV in Uganda |
Paul Park, MS |
Tuberculosis |
|
|
East Africa IEDEA Regional Consortium |
Craig Cohen, MD, MPH |
HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance |
|
|
Novel Biomarkers to Shorten TB Treatment |
Rada Savic, PhD |
Tuberculosis |
|
|
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis |
Laurence Huang, MD |
HIV/AIDS, Tuberculosis |
|
|
Infectious disease laboratories |
George Rutherford, MD |
Infectious Disease, Tuberculosis |
|
|
Evidence Reviews required for the revision of the WHO guidance on the treatment of TB. |
Payam Nahid, MD, MPH |
Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Improving the molecular diagnosis of drug resistant tuberculosis |
Midori Kato-Maeda, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Targeted Behavioral Incentives for Improving Tuberculosis (TB) Diagnostic Evaluation Outcomes |
Priya Shete, MD |
HIV/AIDS, Tuberculosis |
|
|
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Intergovernmental Personnel Agreement (IPA) |
Eric Goosby, MD |
HIV/AIDS, Tuberculosis |
|
|
LOC-IMPAACT Leadership Group |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development |
|
|
Optimal MDR treatment in children |
Rada Savic, PhD |
Tuberculosis, Pediatrics |
|
|
Sputum Transcriptomic Expression Profiling in Study 31 (STEPS 31) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Effects of Air Pollution on Childhood Tuberculosis in Viet Nam |
|
Tuberculosis, Pediatrics |
|
|
UN Special Envoy for Tuberculosis: Strategic Priorities |
Eric Goosby, MD |
Tuberculosis, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Host-Directed Strategies to Create Synergistic Antibacterial Therapies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology |
|
|
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages |
|
Tuberculosis, Immunology |
|
|
The impact of TB co-infection on the reservoir of persistent HIV in vivo |
Mike McCune, MD, PhD |
HIV/AIDS, Tuberculosis, Immunology |
|
|
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda |
Carina Marquez, MD |
Tuberculosis, Pediatrics |
|
|
Impact of Pregnancy on Tuberculosis |
Rada Savic, PhD |
Tuberculosis, Women's Health, Labor and Delivery, Newborn and Infant Health |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Diagnostics, management, & transmission of MDR TB |
John Metcalfe, MD |
Tuberculosis |
|
|
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Office of the UN Special Envoy for Tuberculosis |
Eric Goosby, MD |
Tuberculosis, Policy and Standards of Care |
|
|
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. |
Laurence Huang, MD |
Tuberculosis |
|
|
Streamlined TB Diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Optimal MDR treatment in children |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda |
Carina Marquez, MD |
HIV/AIDS, Tuberculosis, Pediatrics, Epidemiology and Surveillance |
|
|
Regional Training and Medical Consultation Center |
Lisa Chen, MD |
Tuberculosis |
|
|
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure |
Rada Savic, PhD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment |
|
|
Commission on Investing in Health (CIH) Phase 3: Leveraging Global Health 2035 to Shape the SDGs and the Health Investments of Donor, Low-Income and Middle-Income Countries |
|
Tuberculosis, Malaria, Women's Health, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Tuberculosis Free California |
George Rutherford, MD |
Tuberculosis |
|
|
Surveilling the syndemic: Assessment of an integrated tuberculosis and HIV pilot surveillance system in Haiti |
Kristiana Dhillon, MS |
HIV/AIDS, Tuberculosis |
|
|
Evaluation of Novel Tuberculosis Screening Strategies for People living with HIV |
Christina Yoon, MD, MPH |
HIV/AIDS, Tuberculosis |
|
|
Diabetes and Tuberculosis in Brazilian slum settings |
Jayant Rajan, MD |
Tuberculosis, Noncommunicable and/or Chronic Disease, Diabetes, Occupational and Environmental Disease, Access or Barriers to Care, Stigma and Discrimination |
|
|
Automated smear-positive tuberculosis diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Tuberculosis contact tracing in resource poor settings |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Epidemiology and Surveillance |
|
|
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) |
Peter Hunt, MD |
Infectious Disease, HIV/AIDS, Tuberculosis |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo |
Payam Nahid, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Mechanism-Based Integrative Pharmacology Model for Tuberculosis |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
2.1 Project Title ACTG: AIDS Clinical Trials Group |
Francesca Aweeka, PharmD |
Infectious Disease, HIV/AIDS, Tuberculosis |
|
|
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases |
Laurence Huang, MD |
HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease |
|
|
Multiscale System Pharmacology Disease Platform for Tuberculosis |
Rada Savic, PhD |
Tuberculosis |
|
|
Modeling the Reproducibility of Blood Assays for TB Infection |
Adithya Cattamanchi, MD |
Tuberculosis |
|
|
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV |
|
HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection |
Rada Savic, PhD |
Tuberculosis |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
UCSF-GIVI CFAR East Africa Regional Director |
|
HIV/AIDS, Tuberculosis, Malaria, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda |
|
Tuberculosis, Implementation and Behavioral Science |
|
|
Comparative Effectiveness of Rapid Diagnostics for Tuberculosis in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB in Vivo |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Continuing Education for the Curry Center |
Lisa Chen, MD |
Tuberculosis |
|
|
Regional Training and Medical Consultation Center |
Lisa Chen, MD |
Tuberculosis |
|
|
Technical Assistance: The National Tuberculosis and Leprosy Control Program: MDR/XDR TB Curry International Tuberculosis Center University of California, San Francisco |
Philip Hopewell, MD |
Tuberculosis |
|
|
Nonlinear Mixed Effects Modeling of Rifapentine Pharmacokinetics |
Rada Savic, PhD |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis |
|
Tuberculosis, Immunology |
|
|
A Novel Proteomic Approach to Tuberculosis Biomarker Discovery using Human Exosomes |
|
Tuberculosis |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Exploring the role of a novel, polymorphic protein family in M. tuberculosis pathogenesis |
|
Tuberculosis, Immunology |
|
|
Mobile Phone Platform for Genomic Disease Detection |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Genetics |
|
|
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 |
Diane Havlir, MD |
HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
Novel Techniques for the Detections of Pediatric Tuberculosis in Ethiopia |
Caryn Bern, MD, MPH |
Tuberculosis, Pediatrics |
|
|
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors |
Philip Hopewell, MD |
Tuberculosis |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects |
Anne Luetkemeyer, MD |
HIV/AIDS, Tuberculosis |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
HQHIV1003203 |
Philip Hopewell, MD |
HIV/AIDS, Tuberculosis |
|
|
Tuberculosis Epidemiologic Studies Consortium |
George Rutherford, MD |
Tuberculosis |
|
|
Exosomes as Biomarkers for Tuberculosis |
|
Tuberculosis |
|
|
Nonlinear Mixed Effects Modeling of Rifapentine in Children |
Rada Savic, PhD |
Tuberculosis, Pediatrics |
|
|
Novel Technologies to Increase the Accessibility and Accuracy of Tuberculosis Diagnostic Services in Hanoi Province, Vietnam |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Structural and functional studies of M. tuberculosis type VII secretion |
Oren Rosenberg, MD, PhD |
Tuberculosis |
|
|
Manipulation of Macrophage Responses by M. tuberculosis |
|
Tuberculosis |
|
|
Accelerating and Intensifying Tuberculosis Case Finding in Uganda |
|
Tuberculosis, Residencies, Fellowships, and Postdoctoral Training |
|
|
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV |
|
HIV/AIDS, Tuberculosis |
|
|
TB Guideline Observation and Adherence in Low Income Countries (TB GOAL) |
Adithya Cattamanchi, MD |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Clinical and Public Health Impact of Automated Nucleic Acid Testing (Cepheid GeneXpert) to Rule-out Tuberculosis in San Francisco |
|
Tuberculosis |
|
|
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda |
Gabriel Chamie, MD |
HIV/AIDS, Tuberculosis, Epidemiology and Surveillance |
|
|
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay |
Anne Luetkemeyer, MD |
Tuberculosis |
|
|
Quantiferon+Pamp |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings |
John Metcalfe, MD |
HIV/AIDS, Tuberculosis |
|
|
Tuberculosis guidelines and best practices internationally |
Sarah Royce, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis |
|
|
Tuberculosis Epidemiology and Novel Transmission Routes in Rural Tanzania |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Investigation of M. tuberculosis Cytochrome P450 Involvement in Cholesterol Utilization |
|
Tuberculosis |
|
|
TB Physician Services Contract |
Payam Nahid, MD, MPH |
Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science |
|
|
Task Order Supplement to A5267 |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment |
|
|
Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis in Adults |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
WHO Cochrane: Programmatic Management of Drug Resistant Tuberculosis (PMDT) |
|
Tuberculosis |
|
|
Regulation of ESX-1 Secretion and Its Role in Mycobacterium tuberculosis Virulence |
|
Tuberculosis |
|
|
Tuberculosis Risk Reduction Project |
George Rutherford, MD |
Tuberculosis, Implementation and Behavioral Science, Risk Reduction and Prevention |
|
|
TB TO 2015 |
Philip Hopewell, MD |
Tuberculosis |
|
|
Tuberculosis Trial Consortium |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania |
Elizabeth Fair, PhD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance |
|
|
Evaluation of interferon Gamma Release Assays in Overseas Immigration Examination of Children in Moderate and high Burden Countries |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Pediatrics |
|
|
Manipulation of Macrophage Responses by M. tuberculosis |
|
Tuberculosis |
|
|
M tuberculosis Cells from Patients with Tuberculosis |
Midori Kato-Maeda, MD |
Tuberculosis |
|
|
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. Tuberculosis |
Philip Hopewell, MD |
Tuberculosis |
|
|
FIND Xpert MTB assay collaboration at Mulago Hospital |
Laurence Huang, MD |
Tuberculosis |
|
|
Regulation of ESX-1 secretion and its role in M. tuberculosis virulence |
|
Tuberculosis |
|
|
Master Agreement: Tuberculosis Indefinite Quantity Contract (TB IQC) |
Philip Hopewell, MD |
Tuberculosis |
|
|
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis |
Midori Kato-Maeda, MD |
Tuberculosis |
|
|
Conducting Infection Control Assessment and Developing Educational Materials for Mexico |
Philip Hopewell, MD |
Tuberculosis |
|
|
Capacity Building for Management of First Line Drug Resistant TB in Tanzania |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Training and Capacity Building |
|
|
Sputum Processing Methods |
|
Tuberculosis, Drug and Diagnostics Development |
|
|
Frontloaded Sputum Microscopy |
|
Tuberculosis |
|
|
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients |
Adithya Cattamanchi, MD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
Tuberculosis Epidemiologic Studies Consortium |
George Rutherford, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
HIV/TB in Uganda: Punctuated Antiretroviral Therapy |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
Compilation, Synthesis and Grading of Evidence for Questions 5 and 6 |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
Leukopheresis Testing |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans |
|
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
UCSF-FIND Uganda Project |
Laurence Huang, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Determination of the M. tuberculosis proteome interaction map (iMAP) during persistence |
|
Tuberculosis |
|
|
Interplay of Strain and Ethnicity in the Immune Response to M. tuberculosis |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Effectiveness of QuantiFERON-TB Gold (QFT-G) in Contact Tracing |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Task Order #22 Assessing the Integration of Social Network Analysis into Tuberculosis Contact Investigation Practice |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
Oxygen Sensors and P450 Monooxgenases in Mycobacterium tuberculosis |
|
Tuberculosis |
|
|
Population-Based Molecular Epidemiology of Tuberculosis in San Francisco |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance |
|
|
TB Physician Services |
Payam Nahid, MD, MPH |
Tuberculosis |
|
|
Systematic Review Series: Non-commercial antibody detection for the dx of pulmonary TB |
Payam Nahid, MD, MPH |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
Coordination of the Development of Tuberculosis Contact Investigation Policy |
Philip Hopewell, MD |
Tuberculosis, Policy and Standards of Care |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Regional TB Training and Medical Consultation Center (RTMCC) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
To carry out re-analysis of data from 5 studies on use Loop-mediated Isothermal Amplication (TB-Lamp) technology for rapid TB diagnostics, stratification of results and reporting |
Adithya Cattamanchi, MD |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
Systematic Reviews of the Scientific Bases of Antituberculosis Chemotherapy ("Dogma" Review) |
Philip Hopewell, MD |
Tuberculosis, Systematic Reviews and Guideline Development |
|
|
ATS Implementation Guide and Training Modules |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
TB Physician Services |
Payam Nahid, MD, MPH |
Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science |
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health |
|
|
Secretion of Virulence Factors by Mycobacterium tuberculosis |
|
Infectious Disease, HIV/AIDS, Tuberculosis, Genetics |
|
|
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis |
Edwin Charlebois, PhD |
HIV/AIDS, Tuberculosis, Implementation and Behavioral Science |
|
|
Tuberculosis Training Scholarships (TBTS) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Structural Genomics of Persistence Targets from M. Tuberculosis |
|
Tuberculosis |
|
|
Regional TB Training and Medical Consultation Center (RTMCC) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" |
Philip Hopewell, MD |
Tuberculosis, Immunology, Systematic Reviews and Guideline Development |
|
|
Tuberculosis Epidemiologic Studies Consortium |
George Rutherford, MD |
Tuberculosis |
|
|
Evaluation of Smear Microscopy Methods |
Philip Hopewell, MD |
Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Regional TB Training and Medical Consultation Center (RTMCC) |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
Tuberculosis Risk Reduction Project |
George Rutherford, MD |
Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance |
|
|
Manipulation of Macrophage Responses by M. Tuberculosis |
|
Tuberculosis |
|
|
CORE B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Tuberculosis, Immunology |
|
|
Impact of the Number of Contacts on the Transmission of Tuberculosis - a Molecular Epidemiologic Study |
Payam Nahid, MD, MPH |
Tuberculosis, Epidemiology and Surveillance |
|
|
Uncovering How Mycobacterium Tuberculosis Utilizes a Novel Protein Secretion System to Manipulate Host Response During Infection |
|
Tuberculosis |
|
|
Model Tuberculosis Education and Training Center |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
BCP and HBAC Cost-Effectiveness Analysis |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Training and Capacity Building, Patient and Peer Education |
|
|
Development of an Integrated Social Franchising/ Health Co-op Model to Address TB and HIV among Poor in Sub-Saharan Africa |
Dominic Montagu, DrPH |
HIV/AIDS, Tuberculosis, Health Economics and Effectiveness |
|
|
TB Diagnosis Technology |
Adithya Cattamanchi, MD |
Tuberculosis |
|
|
Regional Capacity Building in Low Incidence Areas |
Philip Hopewell, MD |
Tuberculosis, Epidemiology and Surveillance, Engagement in Care |
|
|
HIV/TB in Uganda: Punctuated Antiretroviral Therapy |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis |
|
|
Tuberculosis Epidemiologic Studies Consortium Project |
George Rutherford, MD |
Tuberculosis |
|
|
Core Prevention and Control Project |
Philip Hopewell, MD |
Tuberculosis |
|
|
Targeted Testing and Treatment of Latent TB Infection |
Philip Hopewell, MD |
Tuberculosis |
|
|
Population-Based Molecular Epidemiology of Tuberculosis |
Philip Hopewell, MD |
Tuberculosis |
|
|
Core Requirements: Tuberculosis Epidemiologic Studies Consortium |
Elizabeth Fair, PhD, MPH |
Tuberculosis |
|
|
Master Agreement: Tuberculosis Epidemiologic Studies Consortium |
Philip Hopewell, MD |
Tuberculosis |
|
|
Role of MmpL Transporters in M. Tuberculosis Virulence |
|
Tuberculosis |
|
|
TBRU: Tuberculosis Research Unit, Case Western Reserve University |
Philip Hopewell, MD |
Tuberculosis, Training and Capacity Building |
|
|
Tuberculosis Trials Consortium (TBTC) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|